IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
Sweden
· Delayed Price · Currency is SEK 1.600
-0.016 (-0.99%)
At close: Mar 6, 2026
-64.84% (1Y)
| Market Cap | 135.90M |
| Revenue (ttm) | 57.46M |
| Net Income (ttm) | -110.01M |
| Shares Out | 84.94M |
| EPS (ttm) | -1.64 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 93,154 |
| Average Volume | 362,952 |
| Open | 1.666 |
| Previous Close | 1.616 |
| Day's Range | 1.580 - 1.666 |
| 52-Week Range | 1.310 - 9.600 |
| Beta | 0.51 |
| RSI | 40.63 |
| Earnings Date | Feb 25, 2026 |